title: Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.
authors.forename: Marc H
authors.initials: MH
authors.lastname: Scheetz
authors.forename: John S
authors.initials: JS
authors.lastname: Esterly
authors.forename: Michael
authors.initials: M
authors.lastname: Malczynski
authors.forename: Michael
authors.initials: M
authors.lastname: Postelnick
authors.forename: Chao
authors.initials: C
authors.lastname: Qi
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000494:pharmacology*; D000077726:Doripenem; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D000077726:Doripenem